City

Baltimore (1)

Saint Louis (1)

Tel Hashomer (1)

Overall Status

Completed (3)

Withdrawn (1)

Sign in for free

Phase

phase 4 (2)

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

CardioDex (1)

Johns Hopkins University (1)

National Aeronautics and Space Administration (NASA) (1)

Washington University School of Medicine (1)

Collaborator

Centers for Disease Control and Prevention (1)

Sheba Medical Center (1)

Intervention

closure device (1)

placebo (1)

probiotic (1)

psilocybin (1)

zolpidem (1)

Study Documents

Intervention Type

drug (2)

device (1)

dietary supplement (1)

other (1)

Funder Type

Other (2)

Industry (1)

U.S. Fed (1)

Study Type

Interventional (4)

pharmacologic actions

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Communicable Diseases, Infection, Anti-Infective Agents Trial in Saint Louis (Probiotic, Placebo)

Completed

Communicable Diseases
+4 more

Probiotic
Placebo

Saint Louis, Missouri

Washington University School of Medicine

Mar 29, 2022

Sleep, Cognition, Pharmacologic Actions Trial (Zolpidem)

Completed

Sleep
+2 more

Zolpidem

(no location specified)

May 3, 2018

Psilocybin, Hallucinogens, Pharmacologic Actions Trial in Baltimore (psilocybin)

Completed

Psilocybin
+5 more

psilocybin

Baltimore, Maryland

Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Med

May 19, 2014

Coagulation, Therapeutic Uses, Pharmacologic Actions Trial in Tel Hashomer (closure device)

Withdrawn

Coagulation
+2 more

closure device

Tel Hashomer, Israel

Heart Institute Sheba medical center

Sep 28, 2010